NOS3 and Hyperglycemia: Pathological conditions, such as hyperglycemia and insulin resistance-induced excess fatty acid oxidation, increase endothelial concentrations of N-acetylglucosamine (GlcNAc) [88], leading to the attachment of GlcNAc to eNOS Ser1117.